• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.87% Nasdaq Up 0.34%

    Immunomedics Inc. (IMMU)

    -NasdaqGM
    4.52 Up 0.04(0.89%) 4:00PM EST
    |After Hours : 4.52 0.00 (0.00%) 4:35PM EST
    Add to Portfolio
    Prev Close:4.48
    Open:4.50
    Bid:4.07 x 100
    Ask:4.65 x 3000
    1y Target Est:7.67
    Beta:-0.18
    Next Earnings Date:N/A
    Day's Range:4.38 - 4.58
    52wk Range:3.04 - 6.17
    Volume:568,322
    Avg Vol (3m):768,277
    Market Cap:420.96M
    P/E (ttm):N/A
    EPS (ttm):-0.49
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMMU

    Comparison

    Symbol% ChgMkt Cap
    IMMUUp 0.89%420.96M
    BIIBDown 2.32%83.20B
    GSKUp 0.21%104.43B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):90.39
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.52
    Quarterly EPS Est (Dec-14) :-0.13
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback